Joost H van den Berg Selected Research

Joost H van den Berg Research Topics

12	Neoplasms (Cancer) 04/2024 - 08/2010
11	Melanoma (Melanoma, Malignant) 04/2024 - 10/2014
2	Carcinoma (Carcinomatosis) 01/2021 - 07/2011
1	Body Weight (Weight, Body) 12/2022
1	Carcinogenesis 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Heart Failure 09/2015
1	Cytokine Release Syndrome 09/2015

5	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2019
2	DNA VaccinesIBA 04/2024 - 08/2010
2	HLA-A*02:01 antigenIBA 04/2024 - 09/2015
2	Immune Checkpoint InhibitorsIBA 12/2022 - 10/2021
2	Programmed Cell Death 1 ReceptorIBA 12/2022 - 10/2021
2	EpitopesIBA 10/2021 - 09/2015
2	VaccinesIBA 01/2021 - 07/2011
1	tetanus toxin fragment CIBA 04/2024
1	MART-1 AntigenIBA 04/2024
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2024
1	IpilimumabIBA 12/2022
1	CTLA-4 AntigenIBA 12/2022
1	Antigen Receptors (Antigen Receptor)IBA 12/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	glutaminyl-peptide cyclotransferaseIBA 01/2019
1	cyclic adenosine-5'-trimetaphosphate (ATMP)IBA 11/2018
1	Galectin 3 (LGALS3)IBA 01/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Galectins (Galectin)IBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	CytokinesIBA 09/2015
1	ProcalcitoninIBA 09/2015
1	C-Reactive ProteinIBA 09/2015
1	HLA-A Antigens (HLA-A)IBA 10/2014
1	AntigensIBA 08/2010

6	Therapeutics 12/2022 - 10/2018
3	Tattooing 04/2024 - 09/2017
3	Immunotherapy 01/2019 - 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022
1	Lasers (Laser) 01/2021